Join

Compare · ACCD vs LSAQ

ACCD vs LSAQ

Side-by-side comparison of Accolade Inc. (ACCD) and LifeSci Acquisition II Corp. (LSAQ): market cap, price performance, sector, and recent activity on the wire.

Summary

  • ACCD operates in Consumer Discretionary, while LSAQ operates in Finance - the two are in different parts of the market.
  • ACCD is the larger of the two at $1.18B, about 12.3x LSAQ ($95.8M).
  • ACCD has more recent analyst coverage (25 ratings vs 0 for LSAQ).
MetricACCDLSAQ
Company
Accolade Inc.
LifeSci Acquisition II Corp.
Price
-
-
Market cap
$1.18B
$95.8M
1M return
-
-
1Y return
-
-
Sector
Consumer Discretionary
Finance
Industry
Business Services
Business Services
Exchange
NASDAQ
NASDAQ
IPO
2020
2020
News (4w)
0
0
Recent ratings
25
0
ACCD

Accolade Inc.

Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

LSAQ

LifeSci Acquisition II Corp.

LifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York.

Latest ACCD

Latest LSAQ